DOTS for TB relapse in India: A systematic review

Lung India

Volumn 29, Issue 2, 2012, Pages 147-153

  Azhar, Gulrez ^a  

^a India   (India)

Author keywords

Directly observed therapy; India; relapse; Revised National Tuberculosis Control Program; systematic review

Indexed keywords

ALCOHOLISM; CHEMOTHERAPY; COCHRANE LIBRARY; DATA BASE; DIRECTLY OBSERVED THERAPY; EMBASE; FOLLOW UP; HUMAN; INDIA; MEDLINE; PRACTICE GUIDELINE; QUALITY CONTROL; RELAPSE; RETREATMENT; REVIEW; SEX DIFFERENCE; SHORT COURSE THERAPY; SMOKING; STANDARD; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 84860494717     PISSN: 09702113     EISSN: 0974598X     Source Type: Journal    
DOI: 10.4103/0970-2113.95320     Document Type: Review

References (15)

1. Central TB Division, TB India 2009 RNTCP status report, in TB India. Directorate General of Health Services. New Delhi: MOHFW GoI; 2009.
2. Hill AR, Manikal VM, Riska PF. Effectiveness of directly observed therapy (DOT) for tuberculosis: A review of multinational experience reported in 1990-2000. Medicine (Baltimore) 2002;81:179-93. (Pubitemid 34507205)
3. Mwandumba HC, Squire SB. Fully intermittent dosing with drugs for treating tuberculosis in adults. Cochrane Database Syst Rev 2001;(4):CD000970.
4. Chang KC, Leung CC, Yew WW, Ho SC, Tam CM, et al. A nested case-control study on treatment-related risk factors for early relapse of tuberculosis. Am J Respir Crit Care Med 2004;170:1124-30. (Pubitemid 39488627)
5. Tuberculosis Research Centre (ICMR), Chennai. Trends in initial drug resistance over three decades in a rural community in south India. Indian J Tuberc 2003;50:75-86.
6. Anonymous, Low rate of emergence of drug resistance in sputum positive patients treated with short course chemotherapy. Int J Tuberc Lung Dis 2001;5:40-5.
7. Chandrasekaran V, Gopi PG, Santha T, Subramani R, Narayanan PR. Status of re-registered patients for tuberculosis treatment under DOTS programme. Indian J Tuberc 2007;54:12-6.
8. Cox HS, Morrow M, Deutschmann PW. Long term efficacy of DOTS regimens for tuberculosis: Systematic review. Br Med J 2008;336:484-7. (Pubitemid 351350598)
9. Mehra RK, Dhingra VK, Nish A, Vashist RP. Study of relapse and failure cases of CAT I retreated with CAT II under RNTCP-an eleven year follow up. Indian J Tuberc 2008;55:188-91.
10. Mukherjee A, Sarkar A, Saha I, Biswas B, Bhattacharyya PS. Outcomes of different subgroups of smear-positive retreatment patients under RNTCP in rural West Bengal, India. Rural Remote Health 2009;9:926.
11. Ormerod LP, Prescott RJ. Inter-relations between relapses, drug regimens and compliance with treatment in tuberculosis. Respir Med 1991;85:239-42.
12. Pardeshi GS, Deshmukh D. A comparison of treatment outcome in retreatment versus new smear positive cases of tuberculosis under RNTCP. Indian J Public Health 2007;51:237-9.
13. Santha T, Nazareth O, Krishnamurthy MS, Balasubramanian R, Vijayan VK, Janardhanam B, et al. Treatment of pulmonary tuberculosis with short course chemotherapy in south India-5-year follow up. Tubercle 1989;70:229-33.
14. Thomas A, Gopi PG, Santha T, Chandrasekaran V, Subramani R, Selvakumar N, et al. Predictors of relapse among pulmonary tuberculosis patients treated in a DOTS programme in South India. Int J Tuberc Lung Dis 2005;9:556-61. (Pubitemid 40646843)
15. Volmink J, Garner P. Directly observed therapy for treating tuberculosis (Cochrane Review). Cochrane Database Syst Rev 2007;2:1465-858.